Stocks
International Stem Cell CorporationISCO
OQBHealthcareBiotechnology$0.15
Price as of · delayed, not real-time
A clinical-stage biotechnology firm focused on developing stem cell-based therapies for degenerative diseases, including Parkinson's disease and retinal disorders. Its proprietary pluripotent stem cell platform and neural cell manufacturing capabilities are the primary reasons investors monitor the company's clinical milestones and funding runway.
52W Range: $0.12-$0.54
Congressional Interest in International Stem Cell Corporation (ISCO)
No congressional trades have been disclosed for International Stem Cell Corporation (ISCO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ISCO?
No congressional trades found for this stock.